Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05468489
Title To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Shanghai Henlius Biotech
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.